➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: August 3, 2021

DrugPatentWatch Database Preview

Patent: 5,593,859

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 5,593,859
Title: Synthesis of human procollagens and collagens in recombinant DNA systems
Abstract:The invention is transfected cells, substantially all of which contain at least one human collagen gene and express fibrillar collagen molecules derived using methods for synthesizing collagen and collagen fibrils in said cell lines, and methods for treatment of disorders in humans using said collagen derived from said stable cell lines.
Inventor(s): Prockop; Darwin J. (Philadelphia, PA), Ala-Kokko; Leena (Andalusia, PA), Fertala; Andrzej (Voorhees, NJ), Sieron; Aleksander (Conshohocken, PA), Kivirikko; Kari I. (Oulu, FI), Geddis; Amy (Philadelphia, PA), Pihlajaniemi; Taina (Oulunsalo, FI)
Assignee: Thomas Jefferson University (Philadelphia, PA)
Application Number:08/211,820
Patent Claims:see list of patent claims

Details for Patent 5,593,859

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04 ⤷  Try it Free Thomas Jefferson University (Philadelphia, PA) 2014-01-14 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 5,593,859

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 9222333 ⤷  Try it Free
World Intellectual Property Organization (WIPO) 9307889 ⤷  Try it Free
World Intellectual Property Organization (WIPO) 9717988 ⤷  Try it Free
United States of America 2002098578 ⤷  Try it Free
United States of America 2002142391 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.